Brief: 3D Signatures Signed Collaboration Agreement With Mdxhealth SA To Evaluate Co's Prognostic Test Candidate For Prostate Cancer
March 28 (Reuters) - 3D Signatures Inc DXD.V :
* 3D SIGNATURES - SIGNED COLLABORATION AGREEMENT WITH
MDXHEALTH SA
TO EVALUATE CO'S PROGNOSTIC TEST CANDIDATE FOR PROSTATE CANCER
* 3D SIGNATURES INC - CO, MDXHEALTH WILL SHARE COSTS OF
CONDUCTING
COLLABORATIVE STUDY
* 3D SIGNATURES - ALSO GRANTED MDXHEALTH EXCLUSIVE OPTION TO
NEGOTIATE A LICENSE AGREEMENT FOR THE PROGNOSTIC TEST CANDIDATE
FOR PROSTATE CANCER
Source text for Eikon: ID:nGNX6j1w6M
Further company coverage: DXD.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Telo Genomics
See all newsBrief: Telo Genomics Announces Positive Results Of Smoldering Multiple Myeloma Proof Of Concept Study
Brief: Telo Genomics Announces Final Assignment Of Patents On Hematological Cancers, Liquid Biopsy & Alzheimer's Disease
Brief: Telo Genomics Announces Multiple Myeloma Collaboration With Mayo Clinic
Brief: 3D Signatures Announces Name Change To Telo Genomics Corp
Brief: 3D Signatures Says Current Board And Executive Management Team Do Not Intend To File For Bankruptcy